Publicaciones en colaboración con investigadores/as de Fundación Renal Iñigo Alvarez de Toledo (16)

2022

  1. Loss of humoral response 3 months after SARS-CoV-2 vaccination in the CKD spectrum: the multicentric SENCOVAC study

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 5, pp. 994-999

  2. Persistent kidney dysfunction after acute kidney injury predicts short-term outpatient mortality

    Internal Medicine Journal, Vol. 52, Núm. 5, pp. 834-840

2019

  1. Erratum to “Spanish Clinical Guidelines on Vascular Access for Haemodialysis” [(NEFROLOGÍA) (2019) 39(1) (1–2), (S0211699518301048), (10.1016/j.nefro.2018.07.001)]

    Nefrologia

  2. Erratum: Fe de errores de Guía Clínica Española del Acceso Vascular para Hemodiálisis (Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia (2017) 37 Suppl 1 (1-191) PII: S0211-6995(19)30153-5)

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia

  3. Erratum: Fe de errores de «Guía Clínica Española del Acceso Vascular para Hemodiálisis» (Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia (2017) 37 Suppl 1 (1-191) PII: S0211-6995(18)30104-8)

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia

2017

  1. Spanish Clinical Guidelines on Vascular Access for Haemodialysis

    Nefrologia, Vol. 37, pp. 1-191

2015

  1. A labor and cost effective next generation sequencing of PKHD1 in autosomal recessive polycystic kidney disease patients

    Gene, Vol. 561, Núm. 1, pp. 165-169

  2. ABCB1 (MDR-1) pharmacogenetics of tacrolimus in renal transplanted patients: A Next Generation Sequencing approach

    Clinical Chemistry and Laboratory Medicine, Vol. 53, Núm. 10, pp. 1515-1519

2014

  1. Diversity of killer cell immunoglobulin-like receptor (KIR) genotypes and KIR2DL2/3 variants in HCV treatment outcome

    PLoS ONE, Vol. 9, Núm. 6

  2. Mitochondrial DNA haplogroups and risk of new-onset diabetes among tacrolimus-treated renal transplanted patients

    Gene, Vol. 538, Núm. 1, pp. 195-198

2012

  1. A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping

    Journal of Hepatology, Vol. 56, Núm. 6, pp. 1230-1238

  2. Association between a common KCNJ11 polymorphism (rs5219) and new-onset posttransplant diabetes in patients treated with Tacrolimus

    Molecular Genetics and Metabolism, Vol. 105, Núm. 3, pp. 525-527

2011

  1. Erratum: Pharmacogenetics of tacrolimus after renal transplantation: Analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes (Clinical Chemistry and Laboratory Medicine (2011) 49:5 (825-833))

    Clinical Chemistry and Laboratory Medicine

  2. KCNQ1 gene variants and risk of new-onset diabetes in tacrolimus-treated renal-transplanted patients

    Clinical Transplantation, Vol. 25, Núm. 3

  3. Pharmacogenetics of tacrolimus after renal transplantation: Analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes

    Clinical Chemistry and Laboratory Medicine, Vol. 49, Núm. 5, pp. 825-833

  4. Pharmacogenetics of tacrolimus: Ready for clinical translation

    Kidney International Supplements, Vol. 1, Núm. 2, pp. 58-62